Cargando…

The histone deacetylase inhibitor sodium valproate causes limited transcriptional change in mouse embryonic stem cells but selectively overrides Polycomb-mediated Hoxb silencing

BACKGROUND: Histone deacetylase inhibitors (HDACi) cause histone hyperacetylation and H3K4 hypermethylation in various cell types. They find clinical application as anti-epileptics and chemotherapeutic agents, but the pathways through which they operate remain unclear. Surprisingly, changes in gene...

Descripción completa

Detalles Bibliográficos
Autores principales: Boudadi, Elsa, Stower, Hannah, Halsall, John A, Rutledge, Charlotte E, Leeb, Martin, Wutz, Anton, O’Neill, Laura P, Nightingale, Karl P, Turner, Bryan M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3769143/
https://www.ncbi.nlm.nih.gov/pubmed/23634885
http://dx.doi.org/10.1186/1756-8935-6-11
_version_ 1782283938800074752
author Boudadi, Elsa
Stower, Hannah
Halsall, John A
Rutledge, Charlotte E
Leeb, Martin
Wutz, Anton
O’Neill, Laura P
Nightingale, Karl P
Turner, Bryan M
author_facet Boudadi, Elsa
Stower, Hannah
Halsall, John A
Rutledge, Charlotte E
Leeb, Martin
Wutz, Anton
O’Neill, Laura P
Nightingale, Karl P
Turner, Bryan M
author_sort Boudadi, Elsa
collection PubMed
description BACKGROUND: Histone deacetylase inhibitors (HDACi) cause histone hyperacetylation and H3K4 hypermethylation in various cell types. They find clinical application as anti-epileptics and chemotherapeutic agents, but the pathways through which they operate remain unclear. Surprisingly, changes in gene expression caused by HDACi are often limited in extent and can be positive or negative. Here we have explored the ability of the clinically important HDACi valproic acid (VPA) to alter histone modification and gene expression, both globally and at specific genes, in mouse embryonic stem (ES) cells. RESULTS: Microarray expression analysis of ES cells exposed to VPA (1 mM, 8 h), showed that only 2.4% of genes showed a significant, >1.5-fold transcriptional change. Of these, 33% were down-regulated. There was no correlation between gene expression and VPA-induced changes in histone acetylation or H3K4 methylation at gene promoters, which were usually minimal. In contrast, all Hoxb genes showed increased levels of H3K9ac after exposure to VPA, but much less change in other modifications showing bulk increases. VPA-induced changes were lost within 24 h of inhibitor removal. VPA significantly increased the low transcription of Hoxb4 and Hoxb7, but not other Hoxb genes. Expression of Hoxb genes increased in ES cells lacking functional Polycomb silencing complexes PRC1 and PRC2. Surprisingly, VPA caused no further increase in Hoxb transcription in these cells, except for Hoxb1, whose expression increased several fold. Retinoic acid (RA) increased transcription of all Hoxb genes in differentiating ES cells within 24 h, but thereafter transcription remained the same, increased progressively or fell progressively in a locus-specific manner. CONCLUSIONS: Hoxb genes in ES cells are unusual in being sensitive to VPA, with effects on both cluster-wide and locus-specific processes. VPA increases H3K9ac at all Hoxb loci but significantly overrides PRC-mediated silencing only at Hoxb4 and Hoxb7. Hoxb1 is the only Hoxb gene that is further up-regulated by VPA in PRC-deficient cells. Our results demonstrate that VPA can exert both cluster-wide and locus-specific effects on Hoxb regulation.
format Online
Article
Text
id pubmed-3769143
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-37691432013-09-11 The histone deacetylase inhibitor sodium valproate causes limited transcriptional change in mouse embryonic stem cells but selectively overrides Polycomb-mediated Hoxb silencing Boudadi, Elsa Stower, Hannah Halsall, John A Rutledge, Charlotte E Leeb, Martin Wutz, Anton O’Neill, Laura P Nightingale, Karl P Turner, Bryan M Epigenetics Chromatin Research BACKGROUND: Histone deacetylase inhibitors (HDACi) cause histone hyperacetylation and H3K4 hypermethylation in various cell types. They find clinical application as anti-epileptics and chemotherapeutic agents, but the pathways through which they operate remain unclear. Surprisingly, changes in gene expression caused by HDACi are often limited in extent and can be positive or negative. Here we have explored the ability of the clinically important HDACi valproic acid (VPA) to alter histone modification and gene expression, both globally and at specific genes, in mouse embryonic stem (ES) cells. RESULTS: Microarray expression analysis of ES cells exposed to VPA (1 mM, 8 h), showed that only 2.4% of genes showed a significant, >1.5-fold transcriptional change. Of these, 33% were down-regulated. There was no correlation between gene expression and VPA-induced changes in histone acetylation or H3K4 methylation at gene promoters, which were usually minimal. In contrast, all Hoxb genes showed increased levels of H3K9ac after exposure to VPA, but much less change in other modifications showing bulk increases. VPA-induced changes were lost within 24 h of inhibitor removal. VPA significantly increased the low transcription of Hoxb4 and Hoxb7, but not other Hoxb genes. Expression of Hoxb genes increased in ES cells lacking functional Polycomb silencing complexes PRC1 and PRC2. Surprisingly, VPA caused no further increase in Hoxb transcription in these cells, except for Hoxb1, whose expression increased several fold. Retinoic acid (RA) increased transcription of all Hoxb genes in differentiating ES cells within 24 h, but thereafter transcription remained the same, increased progressively or fell progressively in a locus-specific manner. CONCLUSIONS: Hoxb genes in ES cells are unusual in being sensitive to VPA, with effects on both cluster-wide and locus-specific processes. VPA increases H3K9ac at all Hoxb loci but significantly overrides PRC-mediated silencing only at Hoxb4 and Hoxb7. Hoxb1 is the only Hoxb gene that is further up-regulated by VPA in PRC-deficient cells. Our results demonstrate that VPA can exert both cluster-wide and locus-specific effects on Hoxb regulation. BioMed Central 2013-05-01 /pmc/articles/PMC3769143/ /pubmed/23634885 http://dx.doi.org/10.1186/1756-8935-6-11 Text en Copyright © 2013 Boudadi et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Boudadi, Elsa
Stower, Hannah
Halsall, John A
Rutledge, Charlotte E
Leeb, Martin
Wutz, Anton
O’Neill, Laura P
Nightingale, Karl P
Turner, Bryan M
The histone deacetylase inhibitor sodium valproate causes limited transcriptional change in mouse embryonic stem cells but selectively overrides Polycomb-mediated Hoxb silencing
title The histone deacetylase inhibitor sodium valproate causes limited transcriptional change in mouse embryonic stem cells but selectively overrides Polycomb-mediated Hoxb silencing
title_full The histone deacetylase inhibitor sodium valproate causes limited transcriptional change in mouse embryonic stem cells but selectively overrides Polycomb-mediated Hoxb silencing
title_fullStr The histone deacetylase inhibitor sodium valproate causes limited transcriptional change in mouse embryonic stem cells but selectively overrides Polycomb-mediated Hoxb silencing
title_full_unstemmed The histone deacetylase inhibitor sodium valproate causes limited transcriptional change in mouse embryonic stem cells but selectively overrides Polycomb-mediated Hoxb silencing
title_short The histone deacetylase inhibitor sodium valproate causes limited transcriptional change in mouse embryonic stem cells but selectively overrides Polycomb-mediated Hoxb silencing
title_sort histone deacetylase inhibitor sodium valproate causes limited transcriptional change in mouse embryonic stem cells but selectively overrides polycomb-mediated hoxb silencing
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3769143/
https://www.ncbi.nlm.nih.gov/pubmed/23634885
http://dx.doi.org/10.1186/1756-8935-6-11
work_keys_str_mv AT boudadielsa thehistonedeacetylaseinhibitorsodiumvalproatecauseslimitedtranscriptionalchangeinmouseembryonicstemcellsbutselectivelyoverridespolycombmediatedhoxbsilencing
AT stowerhannah thehistonedeacetylaseinhibitorsodiumvalproatecauseslimitedtranscriptionalchangeinmouseembryonicstemcellsbutselectivelyoverridespolycombmediatedhoxbsilencing
AT halsalljohna thehistonedeacetylaseinhibitorsodiumvalproatecauseslimitedtranscriptionalchangeinmouseembryonicstemcellsbutselectivelyoverridespolycombmediatedhoxbsilencing
AT rutledgecharlottee thehistonedeacetylaseinhibitorsodiumvalproatecauseslimitedtranscriptionalchangeinmouseembryonicstemcellsbutselectivelyoverridespolycombmediatedhoxbsilencing
AT leebmartin thehistonedeacetylaseinhibitorsodiumvalproatecauseslimitedtranscriptionalchangeinmouseembryonicstemcellsbutselectivelyoverridespolycombmediatedhoxbsilencing
AT wutzanton thehistonedeacetylaseinhibitorsodiumvalproatecauseslimitedtranscriptionalchangeinmouseembryonicstemcellsbutselectivelyoverridespolycombmediatedhoxbsilencing
AT oneilllaurap thehistonedeacetylaseinhibitorsodiumvalproatecauseslimitedtranscriptionalchangeinmouseembryonicstemcellsbutselectivelyoverridespolycombmediatedhoxbsilencing
AT nightingalekarlp thehistonedeacetylaseinhibitorsodiumvalproatecauseslimitedtranscriptionalchangeinmouseembryonicstemcellsbutselectivelyoverridespolycombmediatedhoxbsilencing
AT turnerbryanm thehistonedeacetylaseinhibitorsodiumvalproatecauseslimitedtranscriptionalchangeinmouseembryonicstemcellsbutselectivelyoverridespolycombmediatedhoxbsilencing
AT boudadielsa histonedeacetylaseinhibitorsodiumvalproatecauseslimitedtranscriptionalchangeinmouseembryonicstemcellsbutselectivelyoverridespolycombmediatedhoxbsilencing
AT stowerhannah histonedeacetylaseinhibitorsodiumvalproatecauseslimitedtranscriptionalchangeinmouseembryonicstemcellsbutselectivelyoverridespolycombmediatedhoxbsilencing
AT halsalljohna histonedeacetylaseinhibitorsodiumvalproatecauseslimitedtranscriptionalchangeinmouseembryonicstemcellsbutselectivelyoverridespolycombmediatedhoxbsilencing
AT rutledgecharlottee histonedeacetylaseinhibitorsodiumvalproatecauseslimitedtranscriptionalchangeinmouseembryonicstemcellsbutselectivelyoverridespolycombmediatedhoxbsilencing
AT leebmartin histonedeacetylaseinhibitorsodiumvalproatecauseslimitedtranscriptionalchangeinmouseembryonicstemcellsbutselectivelyoverridespolycombmediatedhoxbsilencing
AT wutzanton histonedeacetylaseinhibitorsodiumvalproatecauseslimitedtranscriptionalchangeinmouseembryonicstemcellsbutselectivelyoverridespolycombmediatedhoxbsilencing
AT oneilllaurap histonedeacetylaseinhibitorsodiumvalproatecauseslimitedtranscriptionalchangeinmouseembryonicstemcellsbutselectivelyoverridespolycombmediatedhoxbsilencing
AT nightingalekarlp histonedeacetylaseinhibitorsodiumvalproatecauseslimitedtranscriptionalchangeinmouseembryonicstemcellsbutselectivelyoverridespolycombmediatedhoxbsilencing
AT turnerbryanm histonedeacetylaseinhibitorsodiumvalproatecauseslimitedtranscriptionalchangeinmouseembryonicstemcellsbutselectivelyoverridespolycombmediatedhoxbsilencing